Merck & CO., INC. (MRK) — 10-Q Filings

10-Q Filings (6)

• Merck's Q3 Net Income Soars 83% Amid Strategic Acquisitions — Nov 5, 2025 Risk: medium
  Merck & Co., Inc. reported a significant increase in net income attributable to Merck & Co., Inc. for the three months ended September 30, 2025, reaching $5,785
• Merck's Q2 Soars on Oncology, Vaccine Strength — Aug 5, 2025 Risk: medium
  Merck & Co., Inc. reported robust financial performance for the second quarter of 2025, with revenue reaching $16.5 billion, marking a 12% increase year-over-ye
• Merck & Co. Files Q1 2025 10-Q — May 2, 2025 Risk: low
  Merck & Co., Inc. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial performance and position. Key financial data p
• Merck & Co. Files 3Q24 10-Q Report — Nov 6, 2024 Risk: low
  Merck & Co., Inc. filed its 10-Q for the period ending September 30, 2024. The filing details the company's financial performance and position for the third qua
• Merck & Co. Files 10-Q for Q2 2024 — Aug 5, 2024 Risk: low
  Merck & Co., Inc. filed its 10-Q for the period ending June 30, 2024. The filing details the company's financial performance and position. Key financial data po
• Merck & Co., Inc. Files 10-Q for Period Ending March 31, 2024 — May 3, 2024 Risk: medium
  Merck & Co., Inc. (MRK) filed a Quarterly Report (10-Q) with the SEC on May 3, 2024. Merck & Co., Inc. filed a 10-Q report for the period ending March 31, 2024.

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX